Earlier this month countries such as Norway, Denmark, France, and Germany suspended the use of the AstraZeneca vaccine due to a suspected link to blood clotting. Even at the time of this suspension, authorities emphasized that it was strictly precautionary and that there was no cause for panic. Fortunately, there was no link found between the vaccine and blood clotting, so regular use has resumed. Additionally, the recent clinical trial in the US involving over thirty thousand participants found no evidence of the vaccine causing blood clotting. Research into a possible link between the vaccine and rare blood clots (called CVST) is ongoing and health bodies are regularly reassessing the situation. At the time of writing, it is widely agreed that the benefits of the vaccine drastically outweigh any risk. While we strive to keep the information in this article up-to-date, please check your local health authority for the latest information and regulations.